Immune dysregulation and CD4+ T cell loss in HIV-1 infection

Springer Seminars in Immunopathology

Volumn 18, Issue 3, 1997, Pages 285-303

  Meyaard, Linde ^a,c   Miedema, Frank ^a,b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

APOPTOSIS; ARTICLE; CELL DEATH; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE DEPLETION; PRIORITY JOURNAL; T LYMPHOCYTE;

APOPTOSIS; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CHEMOKINES; CYTOKINES; HIV INFECTIONS; HIV-1; HUMANS; LYMPHOCYTE ACTIVATION; PHENOTYPE; T-LYMPHOCYTES; VARIATION (GENETICS);

EID: 0031048982     PISSN: 03444325     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00813499     Document Type: Article

References (167)

1. Akbar AN, Borthwick NJ, Salmon M, Gombert W, Bofill M, Shamsadeen N, Pilling D, Pett S, Grundy JE, Janossy G (1993) The significance of low bcl-2 expression by CD45RO T cells in normal individuals and patients with acute viral infections. The role of apoptosis in T cell memory. J Exp Med 178:427
2. Akbar AN, Salmon M, Savill J, Janossy G (1993) A possible role for bcl-2 in regulating T cell memory - a 'balancing act' between cell death and survival. Immunol Today 14:526
3. Ameisen JC, Capron A (1991) Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis. Immunol Today 12:102
4. Asjo B, Albert J, Karlsson A, Morfeldt-Månson L, Biberfeld G, Lidman K, Fenyo EM (1986) Replicative properties of human immunodeficiency virus from patients with varying severity of HIV infection. Lancet 11:660
5. - helper cells from normal donors and HIV-infected patients. J Immunol 154:1408
6. Badley AD, McElhinny JA, Leibson PJ, Lynch DH, Alderson MR, Paya CV (1996) Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes. J Virol 70:199
7. Baier M, Werner A, Bannert N, Metzner K, Kurth R (1995) HIV suppression by interleukin-16. Nature 378:563
8. Ballet JJ, Couderc LJ, Rabian-Herzog C, Duval-Roy C, Janier M, Danon F, Clauvel JP, Seligmann M (1988) Impaired T-lymphocyte-dependent immune responses to microbial antigens in patients with HIV-1-associated persistent generalized lymphadenopathy. J Acquir Immune Defic Syndr 2:291
9. Banda NK, Bernier J, Kurahara DK, Kurrle R, Haigwood N, Sekaly R-P, Helman Finkel T (1992) Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J Exp Med 176:1099
10. Barcellini W, Rizzardi GP, Borghi MO, Fain C, Lazzarin A, Meroni PL (1994) Th1 and Th2 cytokine production by peripheral blood mononuclear cells from HIV-infected patients. J Acquir Immune Defic Syndr 8:757
11. Bell SJD, Cooper DA, Kemp BE, Doherty RR, Penny R (1992) Heterogenous effects of exogenous IL-2 on HIV-specific cell-mediated immunity (CMI). Clin Exp Immunol 90:6
12. Bishop CJ, Moss DJ, Ryan JM, Burrows SR (1985) T lymphocytes in infectious mononucleosis. II. Response in vitro to interleukin-2 and establishment of T cell lines. Clin Exp Immunol 60:70
13. Bishop SA, Gruffydd-Jones TJ, Harbour DA, Stokes CR (1993) Programmed cell death (apoptosis) as a mechanism of cell death in peripheral blood mononuclear cells from cats infected with feline immunodeficiency virus (FIV). Clin Exp Immunol 93:65
14. Blatt SP, Hendrix CW, Butzin CA, Freeman TM, Ward WW, Hensley RE, Melcher GP, Donovan DJ, Boswell RN (1993) Delayed type hypersensitivity skin testing predicts progression to AIDS in HIV-infected patients. Ann Intern Med 119:177
15. + patients. Am J Pathol 146:1542
16. Bonyhadi ML, Rabin L, Salimi S, Brown DA, Kosek J, McCune JM, Kaneshima H (1993) HIV induces thymus depletion in vivo. Nature 363:728
17. + T lymphocytes during HIV-1 infection. J Immunol 156:2282
18. + T cells. J Immunol 144:2961
19. + T cells. Evidence for a soluble inhibitor. J Immunol 146:2961
20. Buttke TM, Sandstrom PA (1994) Oxidative stress as a mediator of apoptosis. Immunol Today 15:7
21. + T cells during an immune response to HIV-1 pulsed dendritic cells. AIDS Res Hum Retroviruses 10:61
22. Cao Y, Qin L, Zhang L, Safrit JT, Ho DD (1995) Virologic and immunologic characterization of long-term survivors of Human Immunodeficiency Virus type 1 infection. N Engl J Med 332:201
23. + cells. AIDS Res Hum Retroviruses 11:789
24. + cells from infected and uninfected chimpanzees. Cell Immunol 132:246
25. + cell depletion or CMV infection. Clin Immunol Immunopathol 65:227
26. Cefai D, Debre P, Kaczorek M, Idziorek T, Autran B, Bismuth G (1990) Human immunodeficiency virus-1 glycoproteins gp120 and gp160 specifically inhibit the CD3/T cell-antigen receptor phosphoinositide transduction pathway. J Clin Invest 86:2117
27. Chehimi J, Starr SE, Frank I, Rengaraju M, Jackson SJ, Lianes C, Kobayashi M, Perussia B, Young D, Nickbarg E, Wolf SF, Trinchieri G (1992) Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients. J Exp Med 175:789
28. Chehimi J, Starr SE, Frank I, D'Andrea A, Ma X, MacGregor RR, Sennelier J, Trinchieri G (1994) Impaired interleukin 12 production in human immunodeficiency virus infected patients. J Exp Med 179:1361
29. Cheng-Mayer C, Seto D, Tateno M, Levy JA (1988) Biologic features of HIV-I that correlate with virulence in the host. Science 240:80
30. Clerici M, Shearer GM (1993) A TH 1 -*Tn2 switch is a critical step in the etiology of HIV infection. Immunol Today 14:107
31. Clerici M, Shearer GM (1994) The Th1-Th2 hypothesis of HIV infection: new insights. Immunol Today 15:575
32. + T helper lymphocytes in asymptomatic human immunodeficiency virus infection. Eur J Immunol 21:665
33. Clerici M, Hakim FT, Venzon DJ, Blatt S, Hendrix CW, Wynn TA, Shearer GM (1993) Changes in interleukin-2 and interleukin-4 production in asymptomatic human immunodeficiency virus-seropositive individuals. J Clin Invest 91:759
34. Clerici M, Lucey DR, Berzofsky JA, Pinto LA, Wynn TA, Blatt SP, Dolan MJ, Hendrix CW, Wolf SF, Shearer GM (1993) Restoration of HIV- specific cell-mediated immune responses by interleukin-12 in vitro. Science 262:1721
35. Clerici M, Sarin A, Coffman RL, Wynn TA, Blatt SP, Hendrix CW, Wolf SF, Shearer GM, Henkart PA (1994) Type I/type 2 cytokine modulation of T cell programed cell death as a model for human immunodeficiency virus pathogenesis. Proc Natl Acad Sci USA 91:11811
36. Clerici M, Wynn TA, Berzofsky JA, Blatt SP, Hendrix CW, Sher A, Coffman RL, Shearer GM (1994) Role of interleukin-10 (IL-10) in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus (HIV-1). J Clin Invest 93:768
37. + T cells. Science 270:1811
38. Cohen J (1995) Clinical trials. IL-12 deaths: explanation and a puzzle. Science 270:908
39. + T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1 infected infected individuals. J Virol 67:1772
40. Critchfield JM, Racke MK, Zuniga-Pflücker JC, Cannella B, Raine CS, Goverman J, Lenardo MJ (1994) T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science 263:1139
41. Denis M, Ghadirian E (1994) Dysregulation of interleukin 8, interleukin 10, and interleukin 12 release by alveolar macrophages from HIV type 1-infected subjects. AIDS Res Hum Retroviruses 10:1619
42. Diaz-Mitoma F, Kumar A, Karimi S, Kryworuchko M, Daftarian MP, Creery WD, Filion LG, Cameron W (1995) Expression of IL-10, IL-4 and interferon-gamma in unstimulated and mitogen-stimulated peripheral blood lymphocytes from HIV-seropositive patients. Clin Exp Immunol 102:31
43. Droge W, Eck HP, Mihm S (1992) HIV-induced cysteine deficiency and T cell dysfunction - a rationale for treatment with N-acetylcysteine. Immunol Today 13:211
44. + cell-mediated pathology. Proc Natl Acad Sci USA 91:8097
45. Emilie D, Fior R, Llorente L, Marfaing-Koka A, Peuchmaur M, Devergne O, Jarousse B, Wijdenes J, Boue F, Galanaud P (1994) Cytokines from lymphoid organs of HIV-infected patients: production and role in the immune disequilibrium of the disease and in the development of B lymphomas. Immunol Rev 140:5
46. + T lymphocytes of african green monkeys secrete an immunodeficiency virus-suppressing lymphokine. Proc Natl Acad Sci USA 91:7207
47. Estaquier J, Idziorek T, De Bels F, Barré-Sinoussi F, Hurtrel B, Aubenin A-M, Venet A, Mehtali M, Muchmore E, Michel P, Mouton Y, Girard M, Ameisen JC (1994) Programmed cell death and AIDS: Significance of T cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections. Proc Natl Acad Sci USA 91:9431
48. + T cells from human immunodeficency virus- infected persons. J Exp Med 182:1759
49. Evans LA, McHugh TM, Stites DP, Levy JA (1987) Differential ability of HIV isolates to productively infect human cells. J Immunol 138:3415
50. Eyster ME, Gail MH, Ballard JO, Al-Mondiry H, Goedert JJ (1987) Natural history of human immunodeficiency virus infections in hemophiliacs: effects of T cell subsets, platelet counts, and age. Ann Intern Med 107:1
51. Fan J, Bass HZ, Fahey JL (1993) Elevated IFN-gamma and decreased IL-2 gene expression are associated with HIV infection. J Immunol 151:5031
52. Finkel TH, Tudor-Williams G, Banda NK, Cotton MF, Curiel T, Monks C, Baba TW, Ruprecht RM, Kupfer A (1995) Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nature Med 1:129
53. Fouchier RAM, Groenink M, Kootstra NA, Tersmette M, Huisman HG, Miedema F, Schuitemaker H (1992) Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. J Virol 66:3183
54. Fouchier RAM, Broersen SM, Brouwer M, Tersmette M, Van't Wout AB, Groenink M, Schuitemaker H (1995) Temporal relationship between elongation of the HIV-1 gp120 V2 domain and the conversion towards a syncytium inducing phenotype. AIDS Res Hum Retroviruses 11:1473
55. Frissen PHJ, Van der Ende ME, Ten Napel CHH, Weigel HM, Schreij GS, Kauffmann RH, Koopmans PP, Hoepelman AIM, De Boer JB, Weverling GJ, Haverkamp G, Dowd P, Miedema F, Schuurman R, Boucher CAB, Lange JMA (1994) Zidovudine and interferon-α combination therapy versus zidovu-dine monotherapy in subjects with symptomatic human immunodeficiency virus type 1 infection. J Infect Dis 169:1351
56. Gazzinelli RT, Bala S, Stevens R, Baseler M, Wahl L, Kovacs J, Sher A (1995) HIV infection suppresses type 1 lymphokine and IL-12 responses to Toxoplasma gondii but fails to inhibit the synthesis of other parasite-induced monokines. J Immunol 155:1565
57. Gendelman HE, Baldwin T, Baca-Regen L, Swindells S, Loomis L, Skurkovich S (1994) Regulation of HIV1 replication by interferon alpha: from laboratory bench to bedside. Res Immunol 145:679
58. Giorgi JV, Fahey JL, Smith DC, Hultin LE, Cheng HL, Mitsuyasu RT, Detels R (1987) Early effects of HIV on CD4 lymphocytes in vivo. J Immunol 138:3725
59. Gougeon M, Garcia S, Heeney J, Tschopp R, Lecoeur H, Guetard D, Rame V, Dauguet R, Montagnier L (1993) Programmed cell death in AIDS- related HIV and SIV infections. AIDS Res Hum Retroviruses 9:553
60. Graziosi C, Pantaleo G, Gantt KR, Fortin J-P, Demarest JF, Cohen OJ, Sékaly RF, Fauci AS (1994) Lack of evidence for the dichotomy of ThI and Th2 predominance in HIV-infected individuals. Science 265:248
61. + T cells from human immunodeficiency virus-infected asymptomatic individuals. J Exp Med 175:331
62. Gruters RA, Terpstra FG, De Jong R, Van Noesel CJM, Van Lier RAW, Miedema F (1990) Selective loss of T cell functions in different stages of HIV infection. Eur J Immunol 20:1039
63. Hall SS (1994) IL-12 holds promise against cancer, glimmer of AIDS hope. Science 263:1685
64. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M (1995) Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373:123
65. Ho DD, Perelson AS, Shaw GM (1995) HIV results in the frame (Reply). Nature 375:198
66. Hofmann B, Orskov Lindhardt B, Gerstoft J, Sand Petersen C, Platz P, Ryder LP, Odum N, Dickmeiss E, Nielsen PB, Ullman S, Svejgaard A (1987) Lymphocyte transformation response to pokeweed mitogen as a marker for the development of AIDS and AIDS related symptoms in homosexual men with HIV antibodies. Br Med J 295:293
67. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547
68. + cell clones derived from HIV-infected and uninfected individuals. Cell Immunol 159:271
69. Hyjek E, Lischner HW, Hyslop T, Bartkowiak J, Kubin M, Trinchieri G, Kozbor D (1995) Cytokine patterns during progression to AIDS in children with perinatal HIV infection. J Immunol 155:4060
70. Katsikis PD, Wunderlich ES, Smith CA, Herzenberg LA, Herzenberg L (1995) Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J Exp Med 181:2029
71. + cell counts. J Infect Dis 169:1236
72. Klein MR, van Baalen CA, Holwerda AM, Kerkhof-Garde SR, Bende RJ, Keel IPM, Eeftinck Schattenkerk JKM, Osterhaus ADME, Schuitemaker H, Miedema F (1995) Kinetics of Gag-specific CTL responses during the clinical course of HIV-I infection: a longitudinal analysis of rapid progressors and long-term asymptomatics J Exp Med 181:1365
73. + cell depletion and progression to AIDS. Ann Intern Med 118:681
74. Koot M, Van 't Wout AB, Kootstra NA, De Goede REY, Tersmette M, Schuitemaker H (1996) Relation between changes in cellular load, evolution of viral phenotype, and the clonal composition of virus populations in the course of human immunodeficiency virus type 1 infection. J Infect Dis 173:349
75. Korsmeyer SJ (1992) Bcl-2: a repressor of lymphocyte death. Immunol Today 13:285
76. Kovacs JA, Baseler M, Dewar RJ, Vogel S, Davey RT Jr, Falloon J, Polis MA, Walker RE, Stevens R, Salzman NP, Metcalf JA, Masur H, Lane HC (1995) Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. N Engl J Med 332:567
77. Laurent-Crawford AG, Krust B, Muller S, Rivière Y, Rey-Cuillé MA, Béchet J-M, Montagnier L, Hovanessian AG (1991) The cytopathic effect of HIV is associated with apoptosis. Virology 185:829
78. + T cells from HIV-infected individuals. J Immunol 153:412
79. Li CJ, Friedman DJ, Wang C, Metelev V, Pardee AB (1995) Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science 268:429
80. Lifson JD, Benike CJ, Mark DF, Koths K, Engleman EG (1984) Human recombinant interleukin-2 partly reconstitutes deficient in vitro immune responses of lymphocytes from patients with AIDS. Lancet 1:698
81. + cells expressing gp160 of human immunodeficiency virus type 1. J Virol 68:390
82. Macho A, Castedo M, Marchetti P, Aguilar JJ, Decaudin D, Zamzami N, Girard PM, Uriel J, Kroemer G (1995) Mitochondria! dysfunctions in circulating T lymphocytes from human immunodeficiency virus-1 carriers. Blood 86:2481
83. Mackewicz CE, Yang LC, Lifson JD, Levy JA (1994) Non-cytolytic CD8 T cell anti-HIV responses in primary HIV-1 infection. Lancet 344:1671
84. + T cells from patients with AIDS. Eur J Immunol 17:1685
85. + T cells showing B cell helper function and reduced cytolytic activity in human immunodeficiency virus type 1 infection. J Exp Med 180:489
86. Maggi E, Mazzetti M, Ravina A, Annunziato F, De Carli M, Pesce AM, Del Prete G, Romagnani S (1994) Ability of HIV to promote a Th1 to Th0 shift and to replicate preferentially in Th2 and Th0 cells. Science 265:244
87. Manca F, Habeshaw JA, Dalgleish AG (1990) HIV envelope glycoprotein, antigen specific T cell responses, and soluble CD4. Lancet 335:811
88. Manetti R, Parronchi P, Giudizi MG, Piccinni M-P, Maggi E, Trinchieri G, Romagnani S (1993) Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med 177:1199
89. Manetti R, Gerosa F, Giudizi M-G, Biagiotti R, Parronchi P, Piccinni M-P, Sampognaro S, Maggi E, Romagnani S, Trinchieri G (1994) Interleukin-12 induces stable priming for interferon-gamma (IFN-gamma) production during differentiation of human T helper (Th) cells and transient IFN- gamma production in established Th2 cell clones. J Exp Med 179:1273
90. Margolick JB, Muñoz A, Donnenberg AD, PARK LP, Galai N, Giorgi JV, O'Gorman MRG, Ferbas J, for the Multicenter AIDS Cohort Study (1995) Failure of T cell homeostasis preceding AIDS in HIV-1 infection. Nature Med 1:674
91. Markowitz N, Hansen NI, Wilcosky TC, Hopewell PC, Glassroth J, Kvale PA, Mangura BT, Osmond D, Wallace JM, Rosen MJ, Reichman LB (1993) Tuberculin and anergy testing in HIV-seropositive and HIV-seronegative persons. Ann Intern Med 119:185
92. + T cells in vitro. Differential induction of apoptosis in these cells. J Immunol 152:330
93. Mastino A, Grelli S, Piacemini M, Oliverio S, Favalli C, Perno CF, Garaci E (1993) Correlation between induction of lymphocyte apoptosis and prostaglandin E2 production by macrophages infected with HIV. Cell Immunol 152:120
94. Meyaard L, Otto SA, Jonker RR, Mijnster MJ, Keet RPM, Miedema F (1992) Programmed death of T cells in HIV-1 infection. Science 257:217
95. Meyaard L, Otto SA, Keet IPM, Roos MThL, Miedema F (1994) Programmed death of T cells in HIV-1 infection: no correlation with progression to disease. J Clin Invest 93:982
96. + T cell clones in HIV-1 infection. Blood 84:4262
97. Meyaard L, Hovenkamp E, Otto SA, Miedema F (1996) IL-12- induced IL-10 production by human T cells as a negative feedback for IL-12- induced immune responses. J Immunol 156:2776
98. Meyaard L, Hovenkamp E, Pakker N, Van der Pouw Kraan TCTM. Miedema F (1996) IL-12 production in whole blood cultures from HIV-infected individuals studied in relation to 1L-10 and PGE2 production. Blood (in press)
99. Meyaard L, Hovenkamp E, Keet IPM, Hooibrink B, De Jong IH, Otto SA, Miedema F (1996) Single cell analysis of IL-4 and IFN-gamma production by T cells from HIV infected individuals: decreased IFN-gamma in the presence of preserved IL-4 production. J Immunol (in press)
100. + T helper cell depletion occurs. J Clin Invest 82:1908
101. Miedema F, Tersmette M, Van Lier RAW (1990) AIDS pathogenesis: a dynamic interaction between HIV and the immune system. Immunol Today 11:293
102. Miedema F, Meyaard L, Klein MR (1993) Protection from HIV-1 infection or AIDS? Science 262:1074
103. Miedema F, Meyaard L, Koot M, Klein MR, Roos MThL, Groenink M, Fouchier RAM, Van 't Wout AB, Tersmette M, Schellekens PThA, Schuitemaker H (1994) Changing virus-host interactions in the course of HIV-1 infection. Immunol Rev 140:35
104. Miyawaki T, Uehara T, Nibu R, Tsuji T, Yachie A, Yonehara S, Taniguchi N (1992) Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J Immunol 149:3753
105. Moss AR, Bachetti P, Osmond D, Krampf W, Chaisson RE, Stiles D, Wilber J, Allain JP, Carlson J (1988) Seropositivity of HIV and the development of AIDS or AIDS-related conditions: Three year follow-up of the San Francisco General Hospital cohort. Br Med J 269:745
106. Moss DJ, Bishop CJ, Burrows SR, Ryan JM (1985) T lymphocytes in infectious mononucleosis. I.T cell death in vitro. Clin Exp Immunol 60:61
107. Muro-Cacho CA, Pantaleo G, Fauci AS (1995) Analysis of apoptosis in lymph nodes of HIV-infected persons. Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden. J Immunol 154:5555
108. Murray HW, Hillman JK, Rubin BY, Kelly CD, Jacobs JL, Tyler LW, Donelly DM, Carriero SM, Godbold JH, Roberts RB (1985) Patients at risk for AIDS-related opportunistic infections.Clinical manifestations and impaired gamma interferon production. N Engl J Med 313:1504
109. + cell production of interferon gamma and the clinical spectrum of patients at risk for and with acquired immunodeficiency syndrome. Arch Intern Med 148:1613
110. Navikas V, Link J, Wahren B, Persson C, Link H (1994) Increased levels of interferon-gamma (IFN-gamma), IL-4 and transforming growth factor-β (TGF-β) mRNA expressing blood mononuclear cells in human HIV infection. Clin Exp Immunol 96:59
111. Newell MK, Haughn LJ, Maroun CR, Julius MH (1990) Death of mature T cells by separate ligation of CD4 and the T cell receptor for antigen. Nature 347:286
112. Newman GW, Guarnaccia JR, Vance III EA, Wu J-Y, Remold HG, Kazanjian PH Jr (1994) Interleukin-12 enhances antigen-specific proliferation of peripheral blood mononuclear cells from HIV-positive and negative donors in response to Mycobacterium avium. AIDS 8:1413
113. Nye KE, Knox KA, Pinching AJ (1990) HIV infection of H9 lymphoblastoid cells chronically activates the inositol polyphosphate pathway. AIDS 4:41
114. Orange JS, Wolf SF, Biron CA (1994) Effects of IL-12 on the response and susceptibility to experimental viral infections. J Immunol 152:1253
115. Orange JS, Salazar-Mather TP, Opal SM, Spencer RL, Miller AH, McEwen BS, Biron CA (1995) Mechanism of interleukin 12-mediated toxicities during experimental viral infections: role of tumor necrosis factor and glucocorticoids. J Exp Med 181:901
116. + T lymphocytes by inhibiting interleukin 2 mRNA. Proc Natl Acad Sci USA 87:2379
117. Oyaizu N, McCloskey TW, Coronesi M, Chirmule N, Kalyanaraman VS, Pahwa S (1993) Accelerated apoptosis in peripheral blood mononuclear cells (PBMCs) from human immunodeficiency virus type-1 infected patients and in CD4 cross-linked PBMCs from normal individuals. Blood 82:3392
118. + T lymphocytes provide helper activity for IgE synthesis in human immunodeficiency virus-infected patients with Hyper-IgE. J Exp Med 181:423
119. + T cell clones from HIV-infected patients. J Clin Invest 96:1677
120. Palacio J, Souberbielle BE, Shattock RJ, Robinson G, Manyonda I, Griffin GE (1994) In vitro HIV-1 infection of human cervical tissue. Res Virol 145:155
121. Pandolfi F, Oliva A, Sacco G, Polidori V, Liberatore D, Mezzaroma I, Kurnick JT, Aiuti F (1993) Fibroblast-derived factors preserve viability in vitro of mononuclear cells isolated from subjects with HIV-I infection. J Acquir Immune Defic Syndr 7:323
122. Paxton WA, Martin SR, Tse D, O'Brien TR, Skumick J, Vandevanter NL, Padian N, Braun JF, Kotler DP, Wolinsky SM, Koup RA (1996) Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposures. Nature Med 2:412
123. Purvis SF, Jacobberger JW, Sramkoski RM, Patki AH, Lederman MM (1995) HIV type 1 Tat protein induces apoptosis and death in Jurkat cells. AIDS Res Hum Retroviruses 11:443
124. Razvi ES, Welsh RM (1993) Programmed cell death of T lymphocytes during acute viral infection: a mechanism for virus-induced immune deficiency. J Virol 67:5754
125. Richman DD, Bozzette SA (1994) The impact of the syncytium- inducing phenotype of human immunodeficiency virus on disease progression. J Infect Dis 169:968
126. Roos MTL, Miedema F, Koot M, Tersmette M, Schaasberg WP, Coutinho RA, Schellekens PTA (1995) T cell function in vitro is an independent progression marker for AIDS in human immunodeficiency virus (HIV)-infected asymptomatic individuals. J Infect Dis 171:531
127. Saag MS, Hahn BH, Gibbons J, Li Y, Parks ES, Parks WP, Shaw GM (1988) Extensive variation of human immunodeficiency virus type I in vivo. Nature 334:440
128. Salazar-Gonzalez JF, Moody DJ, Giorgi JV, Martinez-Maza O, Mitsuyasu RT, Fancy JL (1985) Reduced ecto-5′-nucleotidase activity and enhanced OKT 10 and HLA-DR expression on CD8 lym-phocytes in the aquired immune deficiency syndrome: evidence of CDS cell immaturity. J Immunol 135:1778
129. Salk J, Bretcher PA, Salk PL, Clerici M, Shearer GM (1993) A strategy for prophylactic vaccination against HIV. Science 260:1270
130. Salmon M, Pilling D, Borthwick NJ, Viner N, Janossy G, Bacon PA, Akbar AN (1994) The progressive differentiation of primed T cells is associated with an increasing susceptibility to apoptosis. Eur J Immunol 24:892
131. Schellekens PTA, Roos MTL, De WolfF, Lange JMA, Miedema F (1990) Low T cell responsiveness to activation via CD3/TCR is a prognostic marker for AIDS in HIV-1 infected men. J Clin Immunol 10:121
132. + cell decline during progression Io AIDS correlates with HIV-1 phenotype. J Acquir Immune Defic Syndr 6:665
133. Schnittman SM, Psallidopoulos MC, Lane HC, Thompson L, Baseler M, Massari F, Fox CH, Salzman NP, Fauci AS (1989) The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. Science 245:305
134. Schuitemaker H, Kootstra NA, De Goede REY, De WolfF, Miedema F, Tersmette M (1991) Monocytotropic human immunodeficiency virus 1 (HIV-1) variants detectable in all stages of HIV infection lack T cell line tropism and syncytium-inducing ability in primary T cell culture. J Virol 65:356
135. Schuitemaker H, Koot M, Kootstra NA, Dercksen MW, De Goede REY, Van Steenwijk RP, Lange JMA, Eeftink Schattenkerk JKM, Miedema F, Tersmette M (1992) Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T cell-tropic virus populations. J Virol 66:1354
136. Schuitemaker H, Meyaard L, Kootstra NA, Otto SA, Dubbes R, Tersmette M, Heeney JL, Miedema F (1993) Lack of T cell dysfunction and programmed cell death in human immunodeficiency type-1 infected chimpanzees correlates with absence of monocytotropic variants. J Infect Dis 168:1140
137. Seder RA, Grabstein KH, Berzofsky JA, McDyer JF (1995) Cytokine interactions in human immunodeficiency virus-infected individuals: Roles of interleukin (IL)-2, IL-12 and IL-15. J Exp Med 182:1067
138. Shearer GM, Bernstein DC, Tung KSK, Via CS, Redfield R, Salahuddin SZ, Gallo RC (1986) A model for the selective loss of major histocompatibility complex self-restricted T cell immune responses during the development of acquired immune deficiency syndrome (AIDS). J Immunol 137:2514
139. + T cell levels. J Acquir Immune Defic Syndr 7:1159
140. Staal FJT, Ela SW, Roederer M, Anderson MT, Herzenberg LA (1992) Gluthatione deficiency and human immunodeficiency virus infection. Lancet 339:909
141. Stites DP, Moss AR, Bacchetti P, Osmond D, McHugh TM, Wang YJ, Hebert S, Golfer B (1989) Lymphocyte subset analysis to predict progression to AIDS in a cohort of homosexual men in San Francisco. Clin Immunol Immunopathol 52:96
142. + T lymphocytes in acute infectious mononucleosis supporting their susceptibility to programmed cell death. Blood 82:521
143. Teppler H, Kaplan G, Smith K, Cameron P, Montana A, Meyn P, Cohn Z (1993) Efficacy of low doses of the polyethylene glycol derivative of interleukin-2 in modulating the immune response of patients with human immunodeficiency virus type 1 infection. J Infect Dis 167:291
144. Teppler H, Kaplan G, Smith KA, Montana AL, Meyn P, Cohn ZA (1993) Prolonged immunostimulatory effect of low-dose polyethylene glycol interleukin 2 in patients with human immunodeficiency virus type 1 infection. J Exp Med 177:483
145. Terai C, Kombluth RS, Pauza CD, Richman DD, Carson DA (1991) Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1. J Clin Invest 87:1710
146. Tersmette M, De Goede REY, Al BJM, Winkel IN, Gruters RA, Cuypers HTM, Huisman HG, Miedema F (1988) Differential syncytium-inducing capacity of human immunodeficiency virus iso-lates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. J Virol 62:2026
147. Tersmette M, Lange JMA, De Goede REY, De Wolf F, Eeftink Schattenkerk JKM, Schellekens PThA, Coutinho RA, Huisman JG, Goudsmit J, Miedema F (1989) Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality. Lancet 1:983
148. Tindall B, Cooper DA (1991) Primary HIV infection: host responses and intervention strategies. J Acquir Immune Defic Syndr 5:1
149. + T lymphocytes in
150. Van 't Wout AB, Kootstra NA, Mulder-Kampinga GA, Albrecht MA, Scherpbier HJ, Veenstra J, Boer K, Coutinho RA, Miedema F, Schuitemaker H (1994) Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral and vertical transmission J Clin Invest 94:2060
151. Van den Berg AP, Meyaard L, Otto SA, Van Son WJ, Klompmaker IJ, Mesander G, De Leij LHFM, Miedema F, The TH (1995) Cytomegalovirus infection associated with a decreased proliferative capacity and increased rate of apoptosis of peripheral blood lymphocytes. Transplant Proc 27:936
152. Von Briesen H, Becker WB, Henco K, Helm EB, Gelderblom HR, Brede HD, Rubsamen-Waigmann H (1987) Isolation frequency and growth properties of HIV variants: multiple simultaneous variants in a patient demonstrated by molecular cloning. J Med Virol 23:51
153. Vyakarnam A, Matear P, Meager A, Kelly G, Stanley B, Weller I, Beverley P (1991) Altered production of tumour necrosis factors alpha and beta and interferon gamma by HIV-infected individuals. Clin Exp Immunol 84:109
154. + T lymphocytes suppresses HIV replication. Immunology 66:628
155. + cells involves a noncytotoxic mechanism. J Virol 65:5921
156. + T cells from HIV-1 infected individuals inhibit acute infection by human and primate immunodeficiency viruses. Cell Immunol 137:420
157. + T cells is regulated by the antigen-presenting cell. J Immunol 150:3832
158. Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifson JD, Bonhoeffer S, Nowak MA, Hahn BH, Saag MS, Shaw GM (1995) Viral dynamics in human immunodeficiency virus type1 infection. Nature 373:117
159. Wesselborg S, Janssen O, Kabelitz D (1993) Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells. J Immunol 150:4338
160. Westendorp MO, Frank R, Ochsenbauer C, Stricker K, Dhein J, Walczak H, Debatin K-M, Krammer PH (1995) Sensitization to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 375:497
161. + cells without eliminating the infected cells. Cell Immunol 128:628
162. Wood R, Montoya JG, Kundu SK, Schwanz DH, Merigan TC (1993) Safety and efficacy of polyethylene glycol-modified interleukin-2 and zidovudine in human immunodeficiency virus type 1 infection: a phase I/II study. J Infect Dis 167:519
163. + T cell clones and peripheral blood T cells. J Immunol 149:2378
164. + allergen-specific Th2 T cell clones. Int Immunol 6:1091
165. Zauli G, Vitale M, Re MC, Furlini G, Zamai L, Falcieri E, Gibellini D, Visani G, Davis BR, Capitani S, La Plac;a M (1994) In vitro exposure to human immunodeficiency virus type 1 induces apoptotic cell death of the factor-dependent TF-1 hematopoietic cell line. Blood 83:167
166. Zhang M, Gong J, Iyer DV, Jones BE, Modlin RL, Barnes PF (1994) T cell cytokine responses in persons with tuberculosis and human immunodeficiency virus infection. J Clin Invest 94:2435
167. Zinkernagel RM, Hengartner H (1994) T cell mediated immunopathology versus direct cytolysis by virus: implications for HIV and AIDS. Immunol Today 15:262